Grant Medical Center was established in 1900 in downtown Columbus, Ohio as the second member hospital of OhioHealth, a not-for-profit, faith-based healthcare system. Grant Medical Center is a Level I Trauma Center.

There are 434 beds in Ohio Health Research Institute.

During the past decade, Ohio Health Research Institute conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 35 clinical trials were completed, i.e. on average, 53% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 22 clinical trials were completed. i.e. 95.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ohio Health Research Institute" #1 sponsor was "Boston Scientific Corporation" with 18 trials, followed by "Abbott Medical Devices" with 6 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 6 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored and "Edwards Lifesciences" with 5 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ohio Health Research Institute" #1 collaborator was "Boston Scientific Corporation" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 47 trials.

According to Clinical.Site data, the most researched conditions in "Ohio Health Research Institute" are "Coronary Artery Disease" (10 trials), "Peripheral Arterial Disease" (8 trials), "Heart Failure" (6 trials), "Atrial Fibrillation" (5 trials) and "Stroke" (5 trials). Many other conditions were trialed in "Ohio Health Research Institute" in a lesser frequency.

Most popular intervention types in "Ohio Health Research Institute" are "Device" (72 trials), "Drug" (26 trials), "Other" (12 trials), "Procedure" (6 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "PROMUS Element Coronary Stent System" (3 trials), "Aspirin" (2 trials), "Remdesivir" (2 trials) and "Tack Endovascular System" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ohio Health Research Institute" are 100 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ohio Health Research Institute". undefined are not yet recruiting, 18 are recruiting, 21 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 51 completed trials in Ohio Health Research Institute, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Ohio Health Research Institute, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 61 trials that are defined as “Not Applicable".

Ohio Health Research Institute has several departments that took part in Clinical trials: "Grant Medical Center Cancer Care" - 115 trials, "Kenton Oncology, Incorporated" - 15 trials, "Mid Ohio Cardiology" - 4 trials